We are live on ! Find out more
OAM

Oppenheimer Asset Management Portfolio holdings

AUM $8.76B
1-Year Est. Return 23.12%
This Fund
S&P 500
This Quarter Est. Return
+2.96%
1 Year Est. Return
+23.12%
3 Year Est. Return
+69.23%
5 Year Est. Return
+84.02%
10 Year Est. Return
+273.29%
AUM
$3.62B
AUM Growth
+$109M
Cap. Flow
+$29.8M
Cap. Flow %
0.82%
Top 10 Hldgs %
13.63%
Holding
1,787
New
81
Increased
723
Reduced
742
Closed
106

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$7.8M
2
DNB
Dun & Bradstreet
DNB
+$6.42M
3
PNC icon
PNC Financial Services
PNC
+$6.23M
4
PEP icon
PepsiCo
PEP
+$5.76M
5
DIS icon
Walt Disney
DIS
+$4.56M

Sector Composition

Rank Sector Weight
1 Financials 15.38%
2 Healthcare 15.13%
3 Technology 14.47%
4 Industrials 12.84%
5 Consumer Discretionary 8.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VEEV icon
176
Veeva Systems
VEEV
$32.8B
$4.91M 0.14%
80,036
+23,850
+42% +$1.38M
DNB
177
DELISTED
Dun & Bradstreet
DNB
$4.86M 0.13%
44,926
-59,997
-57% -$6.42M
MCD icon
178
McDonald's
MCD
$192B
$4.85M 0.13%
31,654
+928
+3% +$134K
PNR icon
179
Pentair
PNR
$10.4B
$4.8M 0.13%
107,400
+129
+0.1% +$5.64K
VRSK icon
180
Verisk Analytics
VRSK
$25.3B
$4.78M 0.13%
56,652
+11,010
+24% +$891K
ITW icon
181
Illinois Tool Works
ITW
$81.8B
$4.74M 0.13%
33,108
-423
-1% -$59K
CHE icon
182
Chemed
CHE
$7.04B
$4.67M 0.13%
22,858
-1,468
-6% -$292K
UL icon
183
Unilever
UL
$138B
$4.67M 0.13%
76,637
-17,919
-19% -$1.07M
GPN icon
184
Global Payments
GPN
$23.1B
$4.66M 0.13%
51,623
+1,019
+2% +$88.1K
SYK icon
185
Stryker
SYK
$123B
$4.63M 0.13%
33,334
+8,671
+35% +$1.19M
AGN
186
DELISTED
Allergan plc
AGN
$4.62M 0.13%
18,987
-4,345
-19% -$1.02M
RTX icon
187
RTX Corp
RTX
$287B
$4.58M 0.13%
59,610
+10,724
+22% +$803K
CCI icon
188
Crown Castle
CCI
$32.9B
$4.58M 0.13%
45,674
+3,491
+8% +$343K
PPG icon
189
PPG Industries
PPG
$24.5B
$4.54M 0.13%
41,311
+241
+0.6% +$26.1K
RL icon
190
Ralph Lauren
RL
$22.9B
$4.5M 0.12%
61,024
-54,138
-47% -$4.06M
EOG icon
191
EOG Resources
EOG
$78.2B
$4.47M 0.12%
49,408
+1,136
+2% +$105K
NUAN
192
DELISTED
Nuance Communications, Inc.
NUAN
$4.44M 0.12%
294,679
+278,047
+1,672% +$4.36M
FLS icon
193
Flowserve
FLS
$9.62B
$4.44M 0.12%
95,610
+570
+0.6% +$27.5K
AGCO icon
194
AGCO
AGCO
$7.47B
$4.41M 0.12%
65,494
+209
+0.3% +$13.3K
ATHN
195
DELISTED
Athenahealth, Inc.
ATHN
$4.39M 0.12%
31,237
-460
-1% -$57.5K
CL icon
196
Colgate-Palmolive
CL
$72.9B
$4.38M 0.12%
59,148
+909
+2% +$67.5K
TXN icon
197
Texas Instruments
TXN
$252B
$4.38M 0.12%
56,919
-138
-0.2% -$11.1K
AET
198
DELISTED
Aetna Inc
AET
$4.38M 0.12%
28,817
-23,908
-45% -$3.38M
ANSS
199
DELISTED
Ansys
ANSS
$4.34M 0.12%
35,714
-1,402
-4% -$165K
MD icon
200
Pediatrix Medical
MD
$2.15B
$4.34M 0.12%
71,905
-750
-1% -$44.5K

Similar funds

Oppenheimer Asset Management's Q2 2017 Portfolio in Review

As of Q2 2017, Oppenheimer Asset Management held 1,787 positions worth $3.62B, up 3.1% from $3.51B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer Asset Management's Q2 2017 filing shows 81 new, 723 increased, 742 reduced and 106 closed positions. Its largest new stake was Evolent Health: 58,930 shares worth $1.49M. The largest sale was Microsoft, an estimated $7.8M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Technology.

  • Oppenheimer Asset Management's largest Q2 2017 buy was Evolent Health: 58,930 shares worth $1.49M.
  • Oppenheimer Asset Management added most to Johnson Controls International in Q2 2017, an estimated $9.09M increase.
  • Oppenheimer Asset Management's biggest Q2 2017 reduction was Microsoft, cutting an estimated $7.8M.
  • Oppenheimer Asset Management fully exited Nippon Telegraph & Telephone in Q2 2017, selling an estimated $3.36M.
  • Oppenheimer Asset Management's ten largest holdings make up 14% of its $3.62B portfolio in Q2 2017.
  • Oppenheimer Asset Management opened 81 new positions and closed 106 in Q2 2017.
  • Oppenheimer Asset Management's portfolio value rose 3.1% quarter-over-quarter to $3.62B.

Based on Oppenheimer Asset Management's 13F filing for Q2 2017, filed 9 Aug 2017.